Precision medicine approvals and rare disease treatment incentives evaluated
WHO: Aaron Kesselheim, MD, MPH, Director, Program On Regulation Therapeutics And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital WHAT: Kesselh..








